The incidence of other gastroenterological disease following diagnosis of irritable bowel syndrome in the UK: A cohort study

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Canavan, Caroline ^a   Card, Timothy ^a   West, Joe ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CELIAC DISEASE; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INCIDENCE; INFLAMMATORY BOWEL DISEASE; IRRITABLE COLON; MAJOR CLINICAL STUDY; MALE; UNITED KINGDOM; ADOLESCENT; AGE; COLORECTAL NEOPLASMS; COMPLICATION; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; SEX DIFFERENCE; TIME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; IRRITABLE BOWEL SYNDROME; MALE; MIDDLE AGED; SEX FACTORS; TIME FACTORS;

EID: 84907212399     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106478     Document Type: Article

References (31)

1. Lovell RM, Ford AC (2012) Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 10: 712-721.
2. Longstreth GF, Thompson WG, Chey WD, Houghton L a, Mearin F, et al. (2006) Functional bowel disorders. Gastroenterology 130: 1480-1491.
3. Begtrup LM, Engsbro AL, Kjeldsen J, Larsen P V, de Muckadell OS, et al. (2013) A Positive Diagnostic Strategy is Non-Inferior to a Strategy of Exclusion for Patients with Irritable Bowel Syndrome. Clin Gastroenterol Hepatol 11: 956-962.
4. National Iinstitute for Health and Care Excellence (2008) Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care. Clinical guideline 61. guidence.nice.org.uk/cg61.
5. Jones R, Lydeard S (1992) Irritable bowel syndrome in the population. Br Med J 304: 87-90.
6. Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW (1995) Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 109: 1736-1741.
7. Thompson WG, Heaton KW, Smyth GT, Smyth C (2000) Irritable bowel syndrome in general practice: prevalence, characteristics, and referral. Gut 46: 78-82.
8. Spiegel BMR, Farid M, Esrailian E, Talley J, Chang L (2010) Is irritable bowel syndrome a diagnosis of exclusion: a survey of primary care providers, gastroenterologists, and IBS experts. Am J Gastroenterol 105: 848-858.
9. Cash BD, Schoenfeld P, Chey WD (2002) The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 97: 2812-2819.
10. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BMR, et al. (2009) Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 169: 651-658.
11. Porter CK, Cash BD, Pimentel M, Akinseye A, Riddle MS, et al. (2012) Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol 12: 55.
12. García Rodríguez L a, Ruigómez a, Wallander M a, Johansson S, Olbe L (2000) Detection of colorectal tumor and inflammatory bowel disease during follow-up of patients with initial diagnosis of irritable bowel syndrome. Scand J Gastroenterol 35: 306-311.
13. Owens DM, Nelson DK, Talley NJ (1995) The irritable bowel syndrome: longterm prognosis and the physician-patient interaction. Ann Intern Med 122: 107-112.
14. Clinical Practice Research Dataset (2013). Available: http://www.cprd.com/home/. Accessed 23 May 2013.
15. Clinical Practice Research Dataset (2012) CPRD Gold Flat files release notes. July.
16. Puri S (2012) Hospital Episode Statistics (HES) data and GOLD documentation.
17. Huerta C, García Rodríguez LA, Wallander M-A, Johansson S (2002) Risk of irritable bowel syndrome among asthma patients. Pharmacoepidemiol Drug Saf 11: 31-35.
18. Lewis JD, Bilker WB, Weinstein RB, Strom BL (2005) The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 14: 443-451.
19. Rothman K, Greenlad S, Lash T (2008) Design strategies to improve study accuracy. Modern Epidemiology. Philidelphia, USA: Lippincoll, Williams and Wilkins. pp. 168-182.
20. Hennessy S, Bilker WB, Berlin J a, Strom BL (1999) Factors influencing the optimal control-to-case ratio in matched case-control studies. Am J Epidemiol 149: 195-197.
21. Violato M, Gray A, Papanicolas I, Ouellet M (2012) Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis. PLoS One 7: e41308.
22. Lewis JD, Brensinger C, Bilker WB, Strom BL (2002) Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 11: 211-218.
23. Jick H, Jick S, Derby LE, Vasilakis C, Myers MW, et al. (1997) Calcium-channel blockers and risk of cancer. Lancet 349: 525-528.
24. Canavan C, West J, Card T (2014) The epidemiology of irritable bowel syndrome. Clin Epidemiol 6: 71-80.
25. Ruigómez A, García Rodríguez LA, Johansson S, Wallander M-A, García Rodríguez LA (2003) Is hormone replacement therapy associated with an increased risk of irritable bowel syndrome? Maturitas 44: 133-140.
26. West J, Logan RF, Card TR, Smith C, Hubbard R (2003) Fracture risk in people with celiac disease: a population-based cohort study. Gastroenterology 125: 429-436.
27. Talley NJ, Zinsmeister a R, Melton LJ (1995) Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 142: 76-83.
28. Chey WD, Nojkov B, Rubenstein JH, Dobhan RR, Greenson JK, et al. (2010) The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: results from a prospective, controlled US trial. Am J Gastroenterol 105: 859-865.
29. Mein SM, Ladabaum U (2004) Serological testing for coeliac disease in patients with symptoms of irritable bowel syndrome: a cost-effectiveness analysis. Aliment Pharmacol Ther 19: 1199-1210.
30. Fukuba N, Ishihara S, Sonoyama H, Oka A, Kusunoki R, et al. (2013) Prevalence of irritable bowel-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospectice multi-centre findings. New insights into Pathophysiol Funct GI Disord Abstr from UEGW.
31. Corinaldesi R, Stanghellini V, Cremon C, Gargano L, Cogliandro RF, et al. (2009) Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther 30: 245-252.